Preparation and IVIVC evaluation of salvianolic acid B micro-porous osmotic pump pellets

References

• Tang M-K, Ren D-C, Zhang J-T, Du G-H. Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 2002;9:405–9
   PubMed Web of Science ®Google Scholar
• Zhou L, Zuo Z, Chow MSS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005;45:1345–59
   PubMed Web of Science ®Google Scholar
• Liu P, Hu Y-Y, Liu C, et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002;8:679–85
   PubMed Web of Science ®Google Scholar
• Au-Yeung KK, Zhu D-Y, Siow YL. Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis. Biochem Pharmacol 2001;62:483–93
   PubMed Web of Science ®Google Scholar
• Sun L, Wu H, Xu J, Yang X. Effect of Salvianolic acid B on hemorheology in rabbits. Chin J Microcirc 2003;13:19–20
   Google Scholar
• Zhao G-R, Zhang H-M, Ye T-X, et al. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol 2008;6:73–81
   Web of Science ®Google Scholar
• Guo G, Li B, Wang Y, et al. Effects of salvianolic acid B on proliferation, neurite outgrowth and differentiation of neural stem cells derived from the cerebral cortex of embryonic mice. Sci China Life Sci 2010;53:653–62
   PubMed Web of Science ®Google Scholar
• Guo X, Chen X, Li L, et al. LC-MS determination and pharmacokinetic study of six phenolic components in rat plasma after taking traditional Chinese medicinal-preparation: guanxinning lyophilized powder for injection. J Chrom B 2008;873:51–8
   PubMed Web of Science ®Google Scholar
• Xiao P-G, Liu C-X. Immunostimulants in traditional Chinese medicine. In: Wagner H, ed. Immunomodulatory agents plants. Berlin: Springer; 1999:325–56
   Google Scholar
• He Q, Zhang J, Chen F, et al. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles. Biomaterials 2010;31:7785–96
   PubMed Web of Science ®Google Scholar
• Xu W-J, Li N, Gao C-K. Preparation of controlled porosity osmotic pump tablets for salvianolic acid and optimization of the formulation using an artificial neural network method. Acta Pharm Sin B 2011;1:64–70
   Google Scholar
• Zhang L, Han L, Sun X, et al. The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B. Fitoterapia 2012;83:678–89
   PubMed Web of Science ®Google Scholar
• Li J, Liu P, Liu J-P, et al. Bioavailability and foam cells permeability enhancement of Salvianolic Acid B pellets based on drug-phospholipids complex technique. Eur J Pharm Biopharm 2012;83:76–86
   PubMed Web of Science ®Google Scholar
• Santus G, Baker RW. Osmotic drug delivery: a review of the patent literature. J Control Release 1995;35:1–21
   Web of Science ®Google Scholar
• Verma R, Mishra B, Garg S. Osmotically Controlled Oral Drug Delivery 1*. Drug Dev Ind Pharm 2000;26:695–708
   PubMed Web of Science ®Google Scholar
• Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release 2002;79:7–27
   PubMed Web of Science ®Google Scholar
• Phaechamud T, Ritthidej GC. Sustained-release from layered matrix system comprising chitosan and xanthan gum. Drug Dev Ind Pharm 2007;33:595–605
   PubMed Web of Science ®Google Scholar
• Siahi MR, Barzegar-Jalali M, Monajjemzadeh F, et al. Design and evaluation of 1-and 3-layer matrices of verapamil hydrochloride for sustaining its release. AAPS PharmSciTech 2005;6:E626–32
   PubMedGoogle Scholar
• Garg A, Gupta M, Bhargava H. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Eur J Pharm Biopharm 2007;67:725–31
   PubMed Web of Science ®Google Scholar
• Guthmann C, Lipp R, Wagner T, Kranz H. Development of a multiple unit pellet formulation for a weakly basic drug. Drug Dev Ind Pharm 2007;33:341–9
   PubMed Web of Science ®Google Scholar
• Nitz M, Taranto OP. Film coating of theophylline pellets in a pulsed fluid bed coater. Chem Eng Process 2008;47:1412–19
   Web of Science ®Google Scholar
• Schultz P, Kleinebudde P. A new multiparticulate delayed release system: part I: dissolution properties and release mechanism. J Control Release 1997;47:181–9
   Web of Science ®Google Scholar
• Schultz P, Tho I, Kleinebudde P. A new multiparticulate delayed release system: part II: coating formulation and properties of free films. J Control Release 1997;47:191–9
   Web of Science ®Google Scholar
• Muschert S, Siepmann F, Leclercq B, et al. Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets. Eur J Pharm Biopharm 2009;72:130–7
   PubMed Web of Science ®Google Scholar
• Muschert S, Siepmann F, Leclercq B, Siepmann J. Dynamic and static curing of ethylcellulose: PVA-PEG graft copolymer film coatings. Eur J Pharm Biopharm 2011;78:455–61
   PubMed Web of Science ®Google Scholar
• Yong Z. A data analysis program in pharmacokinetics base on microsoft excel – development and validation of PKSlover 1.0. J Math Med 2007;1:58–61
   Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Meth Programs Biomed 2010;99:306–14
   PubMed Web of Science ®Google Scholar
• Emami J. In vitro-in vivo correlation: from theory to applications. J Pharm Pharm Sci 2006;9:169–89
   PubMed Web of Science ®Google Scholar
• Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975;64:1987–91
   PubMed Web of Science ®Google Scholar
• Dashevsky A, Ahmed AR, Mota J. Effect of water-soluble polymers on the physical stability of aqueous polymeric dispersions and their implications on the drug release from coated pellets. Drug Dev Ind Pharm 2010;36:152–60
   PubMed Web of Science ®Google Scholar
• Nesbitt RU. Effect of formulation components on drug release from multiparticulates. Drug Dev Ind Pharm 1994;20:3207–36
   Web of Science ®Google Scholar
• Rohera BD, Parikh NH. Influence of type and level of water-soluble additives on drug release and surface and mechanical properties of Surelease® films. Pharm Dev Technol 2002;7:421–32
   PubMed Web of Science ®Google Scholar
• Wong D, Bodmeier R. The impact of the use of flocculated colloidal dispersions on the drug release from drug-containing films and coated tablets. Pharm Res 1994;11:S185
   PubMed Web of Science ®Google Scholar
• Sakellariou P, Rowe R, White E. Polymer/polymer interaction in blends of ethyl cellulose with both cellulose derivatives and polyethylene glycol 6000. Int J Pharm 1986;34:93–103
   Web of Science ®Google Scholar
• Sakellariou P, Rowe R. The morphology of blends of ethylcellulose with hydroxypropyl methylcellulose as used in film coating. Int J Pharm 1995;125:289–96
   Web of Science ®Google Scholar
• Palmer D, Vuong H, Levina M, Rajabi-Siahboomi AR. The influence of hydrophilic pore formers on dipyridamole release from aqueous ethylcellulose film-coated pellets. AAPS Annual Meeting; 2007
   Google Scholar
• Siepmann F, Hoffmann A, Leclercq B, et al. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Control Release 2007;119:182–9
   PubMed Web of Science ®Google Scholar
• Siepmann F, Muschert S, Leclercq B, et al. How to improve the storage stability of aqueous polymeric film coatings. J Control Release 2008;126:26–33
   PubMed Web of Science ®Google Scholar
• Ozturk A, Ozturk SS, Palsson B, et al. Mechanism of release from pellets coated with an ethylcellulose-based film. J Control Release 1990;14:203–13
   Web of Science ®Google Scholar
• Liu L, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Control Release 2000;67:309–22
   PubMed Web of Science ®Google Scholar